Status:

ACTIVE_NOT_RECRUITING

Post Market Clinical Follow-Up Study Protocol for PROFEMUR® TL Modular Femoral Stems

Lead Sponsor:

MicroPort Orthopedics Inc.

Conditions:

Joint Disease

Eligibility:

All Genders

21+ years

Brief Summary

Sponsor is conducting this post market clinical follow-up (PMCF) study to evaluate the safety and efficacy of its total hip arthroplasty (THA) marketed in the European Union (EU) . These types of stud...

Detailed Description

Total hip arthroplasty (THA) has been performed since the early 1920s and is generally considered to be one of the most successful orthopedic surgeries performed. The 8th Annual Report from the Nation...

Eligibility Criteria

Inclusion

  • Has undergone primary THA for any of the following:
  • Non-inflammatory degenerative joint disease such as osteoarthritis, avascular necrosis, ankylosis, protrusio acetabuli, or painful hip dysplasia;
  • Inflammatory degenerative joint disease such as rheumatoid arthritis; or
  • Correction of functional deformity
  • Subject is implanted with the specified combination of components
  • Subject is willing and able to complete required study visits or assessments

Exclusion

  • Subjects implanted with DYNASTY® BIOFOAM® Acetabular Shells
  • Subjects implanted with a metal-on-metal articulation
  • Subjects implanted with non-MicroPort Orthopedics components (femoral heads, acetabular shells, acetabular liners) in the enrolled THA
  • Subjects skeletally immature (less than 21 years of age) at time of primary THA surgery
  • Subjects currently enrolled in another clinical study which could affect the endpoints of this protocol
  • Subjects unwilling to sign the Informed Consent document
  • Subjects with substance abuse issues
  • Subjects who are incarcerated or have pending incarceration

Key Trial Info

Start Date :

November 1 2014

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

November 1 2028

Estimated Enrollment :

143 Patients enrolled

Trial Details

Trial ID

NCT02239783

Start Date

November 1 2014

End Date

November 1 2028

Last Update

November 18 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ottawa Hospital

Ottawa, Ontario, Canada, K1H-8L6